1978 1980 1981 1982 1983 1984

1985 1986 1987 1988 1989 1990

1992 1993 1994 1995 1996 1997

1998 1999 2000 2001 2002 2003

2004 2005 2006 2007 2008

Laparoscopic partial nephrectomy with a novel electrosurgical snare in a porcine model.
Collyer WC, Landman J, Olweny EO, Andreoni C, Kibel A, Andriole GL, Bostwick DG, Sundaram CP, Clayman RV.

Molecular genetics and histopathologic features of adult distal nephron tumors.
Polascik TJ, Bostwick DG, Cairns P.

Ferromagnetic self-regulating reheatable thermal rod implants for in situ tissue ablation.
Rehman J, Landman J, Tucker RD, Bostwick DG, Sundaram CP, Clayman RV.

Graft-versus-host-like colitis and malignant thymoma.
Lowry PW, Myers JD, Geller A, Bostwick DG, Clain JE.

Urothelial papillary (exophytic) neoplasms.
Bostwick DG, Mikuz G.

Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival.
Bostwick DG, Qian J, Pacelli A, Zincke H, Blute M, Bergstralh EJ, Slezak JM, Cheng L.

Prostatic intraepithelial neoplasia.
Bostwick DG.

Needle core length in sextant biopsy influences prostate cancer detection rate.
Iczkowski KA, Casella G, Seppala RJ, Jones GL, Mishler BA, Qian J, Bostwick DG.

Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
Qian J, Hirasawa K, Bostwick DG, Bergstralh EJ, Slezak JM, Anderl KL, Borell TJ, Lieber MM, Jenkins RB.

Determination of a minimal deletion interval on chromosome band 8p21 in sporadic prostate cancer.
Swalwell JI, Vocke CD, Yang Y, Walker JR, Grouse L, Myers SH, Gillespie JW, Bostwick DG, Duray PH, Linehan WM, Emmert-Buck MR.